<DOC>
	<DOCNO>NCT00168441</DOCNO>
	<brief_summary>4-month study include 30-day baseline phase</brief_summary>
	<brief_title>A Study Evaluating Botulinum Toxin Type A Subjects With Postherpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Postherpetic neuralgia 3 month heal herpes zoster skin rash . Previous use botulinum toxin serotype immunization botulinum toxin serotype .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>